[Optimized RT-PCR based detection of specific genetic abnormalities within malignant hematopoietic disorders]

Area of Science:

• Hematology
• Molecular Genetics
• Oncology

Context:

• Malignant hematopoietic disorders require precise moleculargenetic detection for accurate diagnosis, prognosis, and therapy.
• Existing diagnostic methods can be time-consuming and may not capture all relevant genetic abnormalities.

Purpose:

• To develop and validate a modified, optimized RT-PCR technique for the rapid moleculargenetic detection of specific genetic abnormalities in hematopoietic malignancies.
• To confirm known genetic markers and identify novel ones in a cohort of patients with various blood cancers.

Summary:

• A cohort of 183 patients with malignant hematopoietic disorders underwent analysis using a modified RT-PCR technique on bone marrow aspirates and peripheral blood samples.
• The study moleculargenetically confirmed specific genetic abnormalities, including t(9;22) in CML, t(15;17) and t(11;17) in AML M3 variants, and identified other translocations such as t(5;12), t(8;21), t(9;22), t(6;9), and t(3;21) in various leukemias and myelodysplastic syndromes.
• The described method proved to be simple, specific, and reliable for rapid detection.

Impact:

• The validated RT-PCR technique offers a significant advancement in the rapid and accurate moleculargenetic diagnosis of malignant hematopoietic disorders.
• This method has direct implications for refining differential diagnoses, personalizing therapeutic strategies, and improving prognostic assessments in hematologic oncology.
• Facilitates timely clinical decisions by providing swift and reliable genetic information crucial for patient management.